XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED UNAUDITED INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Subscription Receivable
Accumulated Deficit
Balance at Dec. 31, 2023 $ 35,635,609 $ 1,441 $ 61,501,801 $ (11,250) $ (25,856,383)
Beginning balance, shares at Dec. 31, 2023   14,405,325      
Stock-based compensation expense 435,663   435,663    
Exercise of stock options 1,975   1,975    
Exercise of stock options (in shares)   1,829      
Exercise of warrants 1,360,457 $ 21 1,509,686 (149,250)  
Exercise of warrants (in shares)   206,018      
Proceeds from subscription receivable 11,250     11,250  
Net Income (Loss) (5,051,913)       (5,051,913)
Balance at Mar. 31, 2024 32,393,041 $ 1,462 63,449,125 (149,250) (30,908,296)
Ending balance, shares at Mar. 31, 2024   14,613,172      
Balance at Dec. 31, 2023 35,635,609 $ 1,441 61,501,801 (11,250) (25,856,383)
Beginning balance, shares at Dec. 31, 2023   14,405,325      
Net Income (Loss) (7,943,593)        
Balance at Jun. 30, 2024 35,256,600 $ 1,523 69,055,053 0 (33,799,976)
Ending balance, shares at Jun. 30, 2024   15,221,308      
Balance at Mar. 31, 2024 32,393,041 $ 1,462 63,449,125 (149,250) (30,908,296)
Beginning balance, shares at Mar. 31, 2024   14,613,172      
Stock-based compensation expense and vesting of restricted stock units 662,321 $ 1 662,320    
Stock-based compensation expense and vesting of restricted stock units (in shares)   5,000      
Sale of common stock , net of issuance costs 4,943,668 $ 60 4,943,608    
Sale of common stock , net of issuance costs (in shares)   603,136      
Proceeds from subscription receivable 149,250     149,250  
Net Income (Loss) (2,891,680)       (2,891,680)
Balance at Jun. 30, 2024 35,256,600 $ 1,523 69,055,053 $ 0 (33,799,976)
Ending balance, shares at Jun. 30, 2024   15,221,308      
Balance at Dec. 31, 2024 39,577,095 $ 1,671 80,312,594   (40,737,170)
Beginning balance, shares at Dec. 31, 2024   16,707,441      
Stock-based compensation expense 1,080,082   1,080,082    
Exercise of stock options 19,137 $ 2 19,135    
Exercise of stock options (in shares)   17,557      
Net Income (Loss) (7,306,757)       (7,306,757)
Balance at Mar. 31, 2025 33,369,557 $ 1,673 81,411,811   (48,043,927)
Ending balance, shares at Mar. 31, 2025   16,724,998      
Balance at Dec. 31, 2024 $ 39,577,095 $ 1,671 80,312,594   (40,737,170)
Beginning balance, shares at Dec. 31, 2024   16,707,441      
Exercise of stock options (in shares) 17,557        
Net Income (Loss) $ (13,401,734)        
Balance at Jun. 30, 2025 28,310,293 $ 1,673 82,447,524   (54,138,904)
Ending balance, shares at Jun. 30, 2025   16,724,998      
Balance at Mar. 31, 2025 33,369,557 $ 1,673 81,411,811   (48,043,927)
Beginning balance, shares at Mar. 31, 2025   16,724,998      
Stock-based compensation expense 1,035,713   1,035,713    
Net Income (Loss) (6,094,977)       (6,094,977)
Balance at Jun. 30, 2025 $ 28,310,293 $ 1,673 $ 82,447,524   $ (54,138,904)
Ending balance, shares at Jun. 30, 2025   16,724,998